Recent Updates
Recently added Catalysts
RDY

Dr. Reddy's Laboratories Ltd. 8-2-337, Road No. 3, Banjara Hills, Hyderabad - 500 034, Telangana, India. CIN: L85195TG1984PLC004507 Tel :+91 40 4900 2900 Fax :+91 40 4900 2999 Email :mail@drreddys.com www.drreddys.com

Key Takeaway: Corporate Relationship Department National Stock Exchange of India Ltd. BSE Limited "Exchange Plaza" Dalal Street, Fort Bandra-Kurla Complex, Bandra (East), Mumbai - 400 001 Mumbai - 400 051 Fax Nos.: 022-22723121 / 22723719 Fax Nos.: 022-26598120/ 26598237 Scrip Code: 500124 Scr

Full Press Release Details

Corporate Relationship Department National Stock Exchange of India Ltd.
BSE Limited "Exchange Plaza"
Dalal Street, Fort Bandra-Kurla Complex, Bandra (East),
Mumbai - 400 001 Mumbai - 400 051
Fax Nos.: 022-22723121 / 22723719 Fax Nos.: 022-26598120/ 26598237
Scrip Code: 500124 Scrip Code: DRREDDY-EQ
This is in reference to the audit of our Formulations
Manufacturing Plants ( Vizag SEZ Plant 1 - FTO 7' and Vizag SEZ Plant 2 - FTO 9') at Duvvada,
Visakhapatnam, which was completed on June 21, 2019 and our intimation dated June 22, 2019.
We have now received an EIR from the US FDA,
indicating closure of this audit.
This is for your information.
/s/ Sandeep Poddar
Sandeep Poddar
Company Secretary
CC:- New York Stock Exchange Inc.(Stock Code :RDY)
Last updated: Sep 12, 2019